IONS vs XLK
Ionis Pharmaceuticals Inc (IONS) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
XLK does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. XLK currently screens at market cap $0.
Not investment advice. Open the IONS and XLK stock pages for the full models.
Not investment advice.